Skip to main content
logo
Panacea Biotec Limited (BOM:531349)
India flag India · Delayed Price · Currency is INR
346.70
+15.60 (4.71%)
At close: Apr 15, 2026

Panacea Biotec Revenue

Panacea Biotec had revenue of 1.65B INR in the quarter ending December 31, 2025, with 1.04% growth. This brings the company's revenue in the last twelve months to 6.06B, up 7.55% year-over-year. In the fiscal year ending March 31, 2025, Panacea Biotec had annual revenue of 5.59B, down -0.01%.

Revenue (ttm)
6.06B
Revenue Growth
+7.55%
P/S Ratio
3.51
Revenue / Employee
2.82M
Employees
2,149
Market Cap
21.25B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20255.59B-740.00K-0.01%
Mar 31, 20245.59B992.22M21.57%
Mar 31, 20234.60B-2.01B-30.44%
Mar 31, 20226.61B364.27M5.83%
Mar 31, 20216.25B807.43M14.84%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Aarti Drugs25.22B
Hester Biosciences3.16B
Titan Biotech1.93B
Zenotech Laboratories419.33M
Bharat Immunologicals & Biologicals Corporation76.50M
Genesis IBRC India36.67M
Hindustan Bio Sciences11.35M
Transgene Biotek2.33M
Revenue Rankings

Panacea Biotec News

More News